Pharos iBio Co.
Anyang
About Pharos iBio Co.
Pharos iBio Co. specializing in drug development that develops treatments for intractable diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $42.1M
- Funding stage: IPO
- Last round: Post-IPO Debt (Dec 2025)
- Ticker: kosdaq:388870
- Website: pharosibio.com
- Phone: +82 031 345 6170
Industries & Categories
Biotechnology, Health Care, Information Technology
Canonical: https://fsome.com/organization/pharos-ibio-co-93610 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.